GLOBAL MARKETS LIVE: Moderna, Novax, S&P Global
|11/30/2020 | 08:43am|
Moderna is filing for an emergency authorization of its coronavirus vaccine in the U.S. and Europe. Major consolidation continues in financial data, with S&P Global ready to buy IHS Markit for $44 billion. On a more modest scale, the acquisition of Siltronic by GlobalWafers is no less symbolic in semiconductors.
Moderna will file for emergency authorization of its coronavirus vaccine in the U.S. and Europe on Monday.
Novax has again postponed the start of a U.S. Phase III clinical trial of its investigational Covid-19 vaccine in the U.S., citing a possible start in the coming weeks.
General Motors and Nikola presented today a new version of their cooperation agreement, which no longer provides for GM's entry into the capital of the designer of electric vehicles.
Unilever is now only listed in London, after the final discontinuation of the listing in the Netherlands.
ABN Amro plans to reduce its workforce by a further 15% by 2024.
China authorizes Tesla to start selling its Model Y SUV produced in Shanghai.
Aegon wants to sell its Central and Eastern European business to Vienna Insurance Group for €830 million, to strengthen its balance sheet in a crisis environment.
HSBC is considering abandoning retail banking in the US, the Financial Times reports.
CNOOC and Semiconductor Manufacturing International will be added on the "black list" of the White House.
Mithra's exclusivity on Estetrol applications extended until 2036 in Europe.
Universal Studio opens a Nintendo theme park in Osaka on February 4.
The boss of Japan Exchange resigns after the giant blackout of October.
Australian wine groups are in distress after Beijing's decision to impose customs surcharges on Australian wines.
GLOBAL MARKETS LIVE: Citigroup, Wells Fargo, SAP…
TODAY ON WALL STREET: Muted reaction
The earnings season picks up steam
Biden’s new rescue package
GLOBAL MARKETS LIVE: Qualcomm, Boeing, Visa…